LINC02155

Across TCGA pan-cancer cohorts, LINC02155 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated LINC02155 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher LINC02155 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02155 expression acts as an unfavorable survival marker, although some lineages such as GBM and HNSC show a favorable association.

THCA, KIRC, and UCEC are the cancer types where LINC02155 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.860	0.995	<.001	129	view →
KIRC	DFS	Tertile	All	0.122	0.634	<.001	105	view →
UCEC	DFS	Tertile	All	0.594	0.843	.001	54	view →
LUAD	OS	Tertile	III,IV	0.254	0.528	.005	36	view →
GBM	DFS	Tertile	All	0.784	0.243	.017	24	view →
SARC	OS	Tertile	All	0.108	0.827	<.001	18	view →
SKCM	OS	Tertile	All	0.576	0.792	.021	12	view →
THYM	OS	Tertile	All	0.593	0.930	.020	9	view →
HNSC	DFS	Tertile	All	1.000	0.701	.028	9	view →
LGG	OS	Tertile	All	0.152	0.521	.018	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

LINC02155–THCA (OS)

Open the THCA breakdown →